Overview
Vaccines, as invaluable public health tools, modulate host immune responses to induce prophylactic protection against infectious diseases and also serve as potential therapeutics to treat established diseases, such as food allergies. My research aims to identify environmental exposures that modulate host responses to harmful insults, including pathogens, allergens, and drug abuse while utilizing vaccination to regulate immunity to protect the host from harm. One goal of my research is to identify innovative vaccine strategies that incorporate novel adjuvants and formulations to induce protective immunity against several diseases when applied to a mucosal surface. Our laboratory also focuses on identifying host immune responses that correlate with protection against several diseases, including peanut allergies and opioid use disorder, and developing novel adjuvanted vaccine formulations that enhance the magnitude, durability, and efficacy of protective immunity. We also investigate the innovative contribution of environmental factors on host immune responses, including susceptibility to allergen sensitization and response to immunization. Understanding how or why a particular immune response is induced in a host may lead to developing targeted treatment options that are safer and more effective than current therapies.
Current Appointments & Affiliations
Assistant Professor in Pathology
·
2025 - Present
Pathology,
Clinical Science Departments
Recent Publications
Nasal immunization with compound 48/80-adjuvanted acellular pertussis vaccines is an effective strategy to induce pertussis-specific systemic and mucosal immunity.
Journal Article Clin Exp Vaccine Res · July 2025 PURPOSE: Mast cell activating adjuvants induce vaccine-specific systemic and mucosal immunity when administered intranasally. Bordetella pertussis infects the respiratory tract and caused 0.45% childhood mortality in the United States before implementing p ... Full text Link to item CiteTwo doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl.
Journal Article NPJ Vaccines · March 28, 2025 Opioid overdoses and opioid use disorder (OUD) are major public health concerns. Current treatment approaches for OUD have failed to slow the growth of the opioid crisis. Opioid vaccines have shown pre-clinical success in targeting multiple different opioi ... Full text Link to item CiteA two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanyl.
Journal Article bioRxiv · August 29, 2024 Opioid overdoses and the growing rate of opioid use disorder (OUD) are major public health concerns, particularly in the United States. Current treatment approaches for OUD have failed to slow the growth of the opioid crisis. Opioid vaccines have shown pre ... Full text Link to item CiteRecent Grants
Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose
ResearchPrincipal Investigator · Awarded by University of New Mexico · 2021 - 2028Adjuvant Comparison for Peanut Allergy Immunotherapy
ResearchProject Manager · Awarded by National Institutes of Health · 2022 - 2026Adjuvant Comparison for Peanut Allergy Immunotherapy
ResearchProject Manager · Awarded by National Institutes of Health · 2022 - 2026View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2015
Ph.D.